Research progress in electronic portal imaging device-based in vivo dosimetry verification
Li Liqin,Li Guangjun,Shen Jiuling,Bai Sen
Radiation Oncology Physics Technical Center,West China Hospital,Sichuan University,Chengdu 610041,China (Li LQ,Li GJ,Shen JL,Bai S);School of Physics and Technology,Wuhan University,Wuhan 430072,China (Li LQ,Shen JL)
Abstract： In vivo dosimetry (IVD) is currently the most direct and effective means of quality assurance. The electronic portal imaging device (EPID) has been widely used for IVD verification owing to its favorable dosimetric properties. In recent years,an increasing number of EPID-based IVD studies have emerged around the world. The purpose of this paper is to give an overview of the present progress in EPID-based IVD studies,and to provide a reference for the subsequent application of EPID in IVD.
Li Liqin,Li Guangjun,Shen Jiuling et al. Research progress in electronic portal imaging device-based in vivo dosimetry verification[J]. Chinese Journal of Radiation Oncology, 2017, 26(7): 833-837.
[1] Mijnheer B,Beddar S,Izewska J,et al. In Vivo dosimetry in external beam radiotherapy[J].Med Phys,2013,40(7):070903. DOI:10.1118/1.4811216. [2] van Elmpt W,McDermott L,Nijsten S,et al. A literature review of electronic portal imaging for radiotherapy dosimetry[J]. Radiother Oncol,2008,88(3):289-309. DOI:10.1016/j.radonc.2008.07.008. [3] 胡逸民,张红志,戴建荣.肿瘤放射物理学[M].北京:原子能出版社,1999:9. Hu YM,Zhang HZ,Dai JR.Radiation Physics[M].Beiijng:Atomic Energy Press,1999:9. [4] Winkler P,Georg D.An intercomparison of 11 amorphous silicon EPIDs of the same type:implications for portal dosimetry[J]. Phys Med Biol,2006,51(17):4189-4200. DOI:10.1088/0031-9155/51/17/005. [5] McDermott LN,Louwe RJW,Sonke JJ,et al. Dose-response and ghosting effects of an amorphous silicon electronic portal imaging device[J]. Med Phys,2004,31(2):285-295. DOI:10.1118/1.1637969. [6] Greer PB.Correction of pixel sensitivity variation and off-axis response for amorphous silicon EPID dosimetry[J]. Med Phys,2005,32(12):3558-3568.DOI:10.1118/1.2128498. [7] Kirkby C,Sloboda R.Consequences of the spectral response of an a-Si EPID and implications for dosimetric calibration[J]. Med Phys,2005,32(8):2649-2658.DOI:10.1118/1.1984335. [8] Gustafsson H,Vial P,Kuncic Z,et al. EPID dosimetry:effect of different layers of materials on absorbed dose response[J]. Med Phys,2009,36(12):5665-5674.DOI:10.1118/1.3245886. [9] Jin GH,Zhu JH,Chen LX,et al. Gantry angle-dependent correction of dose detection error due to panel position displacement in IMRT dose verification using EPIDS[J].Phys Med,2014,30(2):209-214.DOI:10.1016/j.ejmp.2013.05.042. [10] Louwe RJW,McDermott LN,Sonke JJ,et al. The long-term stability of amorphous silicon flat panel imaging devices for dosimetry purposes[J].Med Phys,2004,31(11):2989-2995.DOI:10.1118/1.1803751. [11] Parent L,Seco J,Evan PM,et al. Monte Carlo modelling of a-Si EPID response:the effect of spectral variations with field size and position[J].Med Phys,2006,33(12):4527-4540. DOI:10.1118/1.2369465. [12] Winkler P,Hefner A,Georg D.Dose-response characteristics of an amorphous silicon EPID[J].Med Phys,2005,32(10):3095-3105. DOI:10.1118/1.2040711. [13] Chen J,Chuang CF,Morin O,et al. Calibration of an amorphous-silicon flat panel portal imager for exit-beam dosimetry[J].Med Phys,2006,33(3):584-594. DOI:10.1118/1.2168294. [14] Nijsten SMJJG,van Elmpt WJC,Jacobs M,et al. A global calibration model for a-Si EPIDs used for transit dosimetry[J].Med Phys,2007,34(10):3872-3884. DOI:10.1118/1.2776244. [15] Greer PB,Popescu CC.Dosimetric properties of an amorphous silicon electronic portal imaging device for verification of dynamic intensity modulated radiation therapy[J].Med Phys,2003,30(7):1618-1627.DOI:10.1118/1.1582469. [16] Greer PB.Off-axis dose response characteristics of an amorphous silicon electronic portal imaging device[J].Med Phys,2007,34(10):3815-3824.DOI:10.1118/1.2779944. [17] Grein EE,Lee R,Luchka K.An investigation of a new amorphous silicon electronic portal imaging device for transit dosimetry[J].Med Phys,2002,29(10):2262-2268. DOI:10.1118/1.1508108. [18] Chytyk K,McCurdy BMC.Comprehensive fluence model for absolute portal dose image prediction[J].Med Phys,2009,36(4):1389-1398. DOI:10.1118/1.3083583. [19] McCurdy BMC,Luchka K,Pistorius S.Dosimetric investigation and portal dose image prediction using an amorphous silicon electronic portal imaging device[J].Med Phys,2001,28(6):911-924.DOI:10.1118/1.1374244. [20] McCurdy BMC,Pistorius S.Photon scatter in portal images:accuracy of a fluence based pencil beam superposition algorithm[J].Med Phys,2000,27(5):913-922. DOI:10.1118/1.598957. [21] Greer PB,Vial P,Oliver L,et al. Experimental investigation of the response of an amorphous silicon EPID to intensity modulated radiotherapy beams[J].Med Phys,2007,34(11):4389-4398. DOI:10.1118/1.2789406. [22] Siebers JV,Kim JO,Ko L,et al. Monte Carlo computation of dosimetric amorphous silicon electronic portal images[J].Med Phys,2004,31(7):2135-2146. DOI:10.1118/1.1764392. [23] Jung JW,Kim JO,Yeo IJ,et al. Fast transit portal dosimetry using density-scaled layer modeling of aSi-based electronic portal imaging device and Monte Carlo method[J].Med Phys,2012,39(12):7593-7602.DOI:10.1118/1.4764563. [24] Yoon J,Jung JW,Kim JO.A Monte Carlo calculation model of electronic portal imaging device for transit dosimetry through heterogeneous media[J].Med Phys,2016,43(5):2242-2250. DOI:10.1118/1.4945276. [25] Berry SL,Sheu RD,Polvorosa CS,et al. Implementation of EPID transit dosimetry based on a through-air dosimetry algorithm[J].Med Phys,2012,39(1):87-98. DOI:10.1118/1.3665249. [26] van Zijtveld M,Dirkx M,Breuers M,et al. Portal dose image prediction for in vivo treatment verification completely based on EPID measurements[J].Med Phys,2009,36(3):9 46-952. DOI:10.1118/1.3070545. [27] Popescu IA,Atwal P,Lobo J,et al. Patient-specific Qa using 4 d Monte Carlo phase space predictions and EPID dosimetry[J].J Phys Conf Ser,2015,573(1):012004. DOI:10.1088/1742-6596/573/1/012004. [28] Fuangrod T,Woodruff HC,van Uytven E,et al. A system for EPID-based real-time treatment delivery verification during dynamic IMRT treatment[J].Med Phys,2013,40(9):091907. DOI:10.1118/1.4817484. [29] Piermattei A,Fidanzio A,Stimato G,et al. In vivo dosimetry by an aSi-based EPID[J].Med Phys,2006,33(11):4414-4422. DOI:10.1118/1.2360014. [30] Cilla S,Azario L,Greco F,et al. An in-vivo dosimetry procedure for Elekta step and shoot IMRT[J].Phys Med,2014,30(4):419-426. DOI:10.1016/j.ejmp.2013.11.005. [31] Fidanzio A,Porcelli A,Azario L,et al. Quasi real time in vivo dosimetry for VMAT[J].Med Phys,2014,41(6):062103. DOI:10.1118/1.4875685. [32] Angelo P,Savino C,Luca G,et al. Integration between in vivo dosimetry and image guided radiotherapy for lung tumors[J].Med Phys,2009,36(6):2206-2214. DOI:10.1118/1.3129158. [33] Francois P,Boissard P,Berger L,et al. In vivo dose verification from back projection of a transit dose measurement on the central axis of photon beams[J].Phys Med,2011,27(1):1-10.DOI:10.1016/j.ejmp.2010.06.002. [34] Louwe RJW,Damen EMF,van Herk M,et al. Three-dimensional dose reconstruction of breast cancer treatment using portal imaging[J].Med Phys,2003,30(9):2376-2389.DOI:10.1118/1.1589496. [35] Yeo IJ,Jung JW,Chew M,et al. Dose reconstruction for intensity-modulated radiation therapy using a non-iterative method and portal dose image[J].Phys Med Biol,2009,54(17):5223-5236.DOI:10.1088/0031-9155/54/17/010. [36] Wendling M,McDermott LN,Mans A,et al. A simple backprojection algorithm for 3D in vivo EPID dosimetry of IMRT treatments[J].Med Phys,2009,36(7):3310-3321.DOI:10.1118/1.3148482. [37] Mans A,Remeijer P,Olaciregui-Ruiz I,et al.3D dosimetric verification of volumetric-modulated arc therapy by portal dosimetry[J].Radiother Oncol,2010,94(2):181-187.DOI:10.1016/j.radonc.2009.12.020. [38] Wendling M,McDermott LN,Mans A,et al. In aqua vivo EPID dosimetry[J].Med Phys,2012,39(1):367-377.DOI:10.1118/1.3665709. [39] Van Uytven E,Van Beek T,McCowan PM,et al. Validation of a method for in vivo 3D dose reconstruction for IMRT and VMAT treatments using on-treatment EPID images and a model-based forward-calculation algorithm[J].Med Phys,2015,42(12):6945-6954.DOI:10.1118/1.4935199. [40] McCowan PM,Van Uytven E,Van Beek T,et al. An in vivo dose verification method for SBRT-VMAT delivery using the EPID[J].Med Phys,2015,42(12):6955-6963.DOI:10.1118/1.4935201. [41] Chytyk-Praznik K,VanUytven E,vanBeek TA,et al. Model-based prediction of portal dose images during patient treatment[J].Med Phys,2013,40(3):031713.DOI:10.1118/1.4792203. [42] Kirkby C,Sloboda R.Comprehensive Monte Carlo calculation of the point spread function for a commercial a-Si EPID[J].Med Phys,2005,32(4):1115-1127.DOI:10.1118/1.1869072. [43] Rowshanfarzad P,McCurdy BMC,Sabet M,et al. Measurement and modeling of the effect of support arm backscatter on dosimetry with a Varian EPID[J].Med Phys,2010,37(5):2269-2278.DOI:10.1118/1.3369445. [44] Rowshanfarzad P,Sabet M,O′Connor DJ,et al. Detection and correction for EPID and gantry sag during arc delivery using cine EPID imaging[J].Med Phys,2012,39(2):623-635.DOI:10.1118/1.3673958. [45] Woodruff HC,Fuangrod T,Rowshanfarzad P,et al. Gantry-angle resolved VMAT pretreatment verification using EPID image prediction[J].Med Phys,2013,40(8):081715.DOI:10.1118/1.4816384. [46] van Zijtveld M,Dirkx M,Breuers M,et al. Evaluation of the ‘dose of the day’ for IMRT prostate cancer patients derived from portal dose measurements and cone-beam CT[J].Radiother Oncol,2010,96(2):172-177.DOI:10.1016/j.radonc.2010.05.015. [47] van Elmpt W,Nijsten S,Petit S,et al.3D in vivo dosimetry using megavoltage cone-beam CT and EPID dosimetry[J].Int J Radiat Oncol Biol Phys,2009,73(5):1580-1587.DOI:10.1016/j.ijrobp.2008.11.051. [48] Jarry G,Verhaegen F.Patient-specific dosimetry of conventional and intensity modulated radiation therapy using a novel full Monte Carlo phase space reconstruction method from electronic portal images[J].Phys Med Biol,2007,52(8):2277-2299.DOI:10.1088/0031-9155/52/8/016.
2017, Vol. 26 
